Naseem Zojwalla

Business address
C/O Olema Pharmaceuticals, Inc., 512 2 Nd Street, 4 Th Floor, San Francisco, CA, 94107
Top holdings (ownership)
OLMA
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Naseem Zojwalla has filed 22 SEC EDGAR filings since 03 Feb 2022

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 23 Dec 2025 19 Dec 2025 001-39712
144 Open Document Open Filing 23 Dec 2025
144 Open Document Open Filing 22 Dec 2025
144 Open Document Open Filing 19 Dec 2025
4 Open Document Open Filing 03 Mar 2025 28 Feb 2025 001-39712
4 Open Document Open Filing 17 Dec 2024 16 Dec 2024 001-39712
4 Open Document Open Filing 11 Dec 2024 09 Dec 2024 001-39712
144 Open Document Open Filing 11 Dec 2024
144 Open Document Open Filing 10 Dec 2024
4 Open Document Open Filing 28 May 2024 24 May 2024 001-39712
4 Open Document Open Filing 20 Mar 2024 18 Mar 2024 001-39712
4 Open Document Open Filing 05 Feb 2024 01 Feb 2024 001-39712
4 Open Document Open Filing 29 Jan 2024 25 Jan 2024 001-39712
4 Open Document Open Filing 12 Dec 2023 11 Dec 2023 001-39712
4 Open Document Open Filing 07 Dec 2023 06 Dec 2023 001-39712
3/A Open Document Open Filing 07 Dec 2023 07 Dec 2023 001-39712
4 Open Document Open Filing 22 Nov 2023 20 Nov 2023 001-39712
144 Open Document Open Filing 22 Nov 2023
144 Open Document Open Filing 21 Nov 2023
4 Open Document Open Filing FORM 4 SUBMISSION 02 Feb 2023 01 Feb 2023 001-39712
4 Open Document Open Filing 03 Feb 2022 01 Feb 2022 001-39712
3 Open Document Open Filing 03 Feb 2022 31 Jan 2022 001-39712